BACKGROUND: The African Rotavirus Surveillance Network has been detecting and documenting rotavirus genotypes in the subcontinent since 1998, largely based on intercountry workshops conducted at Rotavirus Regional Reference Laboratories. This article reports on rotavirus genotypes generated at Regional Reference Laboratories, South Africa between 2007 and 2011 from 16 African countries. METHODS: Stool samples were collected from <5-year-old children with diarrhea following World Health Organization criteria of hospital-based rotavirus surveillance. Enzyme immunoassay (EIA) was performed by National Laboratories. Regional Reference Laboratories retested 10% of randomly selected EIA positives and 10% of EIA negatives from each country as part of quality control. At least 50 rotavirus EIA positives from each country per year were subjected to reverse transcriptase polymerase chain reaction based on G-/P-types. Sequencing was conducted in 5-10% of each representative G or P genotype to confirm the genotype, as well as to type some of the samples that could not be genotyped with reverse transcriptase polymerase chain reaction-based methods. RESULTS: A total of 2555 of rotavirus EIA positives were genotyped. G1 was the most predominant (28.8%), followed by G9 (17.3%), G2 (16.8%), G8 (8.2%), G12 (6.2%) and G3 (5.9%). Similarly, the P[8] strain was the most prevalent (40.6%), followed by P[6] (30.9%) and P[4] (13.9%). The top G/P combinations detected were G1P[8] (18.4%), G9P[8] (11.7%), G2P[4] (8.6%), G2P[6] (6.2%), G1P[6] (4.9%), G3P[6] (4.3%), G8P[6] (3.8%) and G12P[8] (3.1%). CONCLUSIONS: There is high genetic diversity of rotavirus strains circulating in the subcontinent. Understanding the strain diversity pre- and postvaccine introduction are important in Africa to understand the broader impact of the rotavirus vaccines on regionally circulating strains.
BACKGROUND: The African Rotavirus Surveillance Network has been detecting and documenting rotavirus genotypes in the subcontinent since 1998, largely based on intercountry workshops conducted at Rotavirus Regional Reference Laboratories. This article reports on rotavirus genotypes generated at Regional Reference Laboratories, South Africa between 2007 and 2011 from 16 African countries. METHODS: Stool samples were collected from <5-year-old children with diarrhea following World Health Organization criteria of hospital-based rotavirus surveillance. Enzyme immunoassay (EIA) was performed by National Laboratories. Regional Reference Laboratories retested 10% of randomly selected EIA positives and 10% of EIA negatives from each country as part of quality control. At least 50 rotavirus EIA positives from each country per year were subjected to reverse transcriptase polymerase chain reaction based on G-/P-types. Sequencing was conducted in 5-10% of each representative G or P genotype to confirm the genotype, as well as to type some of the samples that could not be genotyped with reverse transcriptase polymerase chain reaction-based methods. RESULTS: A total of 2555 of rotavirus EIA positives were genotyped. G1 was the most predominant (28.8%), followed by G9 (17.3%), G2 (16.8%), G8 (8.2%), G12 (6.2%) and G3 (5.9%). Similarly, the P[8] strain was the most prevalent (40.6%), followed by P[6] (30.9%) and P[4] (13.9%). The top G/P combinations detected were G1P[8] (18.4%), G9P[8] (11.7%), G2P[4] (8.6%), G2P[6] (6.2%), G1P[6] (4.9%), G3P[6] (4.3%), G8P[6] (3.8%) and G12P[8] (3.1%). CONCLUSIONS: There is high genetic diversity of rotavirus strains circulating in the subcontinent. Understanding the strain diversity pre- and postvaccine introduction are important in Africa to understand the broader impact of the rotavirus vaccines on regionally circulating strains.
Authors: Martin M Nyaga; Karla M Stucker; Mathew D Esona; Khuzwayo C Jere; Bakari Mwinyi; Annie Shonhai; Enyonam Tsolenyanu; Augustine Mulindwa; Julia N Chibumbya; Hokororo Adolfine; Rebecca A Halpin; Sunando Roy; Timothy B Stockwell; Chipo Berejena; Mapaseka L Seheri; Jason M Mwenda; A Duncan Steele; David E Wentworth; M Jeffrey Mphahlele Journal: Virus Genes Date: 2014-06-22 Impact factor: 2.332
Authors: Mark Zeller; Elisabeth Heylen; Susan Damanka; Corinna Pietsch; Celeste Donato; Tsutomu Tamura; Ruta Kulkarni; Ritu Arora; Nigel Cunliffe; Leena Maunula; Christiaan Potgieter; Sana Tamim; Sarah De Coster; Elena Zhirakovskaya; Salwa Bdour; Helen O'Shea; Carl D Kirkwood; Mapaseka Seheri; Martin Monene Nyaga; Jeffrey Mphahlele; Shobha D Chitambar; Ron Dagan; George Armah; Nina Tikunova; Marc Van Ranst; Jelle Matthijnssens Journal: Mol Biol Evol Date: 2015-04-08 Impact factor: 16.240
Authors: Mathew D Esona; Rashi Gautam; Ka Ian Tam; Alice Williams; Slavica Mijatovic-Rustempasic; Michael D Bowen Journal: J Virol Methods Date: 2015-07-29 Impact factor: 2.014
Authors: Martin M Nyaga; Yi Tan; Mapaseka L Seheri; Rebecca A Halpin; Asmik Akopov; Karla M Stucker; Nadia B Fedorova; Susmita Shrivastava; A Duncan Steele; Jason M Mwenda; Brett E Pickett; Suman R Das; M Jeffrey Mphahlele Journal: Infect Genet Evol Date: 2018-05-18 Impact factor: 3.342
Authors: Martin M Nyaga; Khuzwayo C Jere; Mathew D Esona; Mapaseka L Seheri; Karla M Stucker; Rebecca A Halpin; Asmik Akopov; Timothy B Stockwell; Ina Peenze; Amadou Diop; Kader Ndiaye; Angeline Boula; Gugu Maphalala; Chipo Berejena; Jason M Mwenda; A Duncan Steele; David E Wentworth; M Jeffrey Mphahlele Journal: Infect Genet Evol Date: 2015-02-17 Impact factor: 3.342
Authors: Diane Waku-Kouomou; Mathew D Esona; Elizabeth Pukuta; Ionela Gouandijka-Vasilache; Angeline Boula; Benjamin A Dahl; Vital Mondonge; David Mekontso; Gilbert Guifara; Regis Mbary-Daba; Jamie Lewis; Ali Ahmed Yahaya; Jason M Mwenda; Kathleen F Cavallaro; Jean Chrysostome Gody; Jean-Jacques Muyembe; Paul Koki-Ndombo; Michael D Bowen Journal: Trop Med Int Health Date: 2015-11-16 Impact factor: 3.918
Authors: G M Giammanco; F Bonura; F DI Bernardo; A Cascio; G Ferrera; P Dones; L Saporito; A Collura; D M Terranova; M Valenzise; M T Allù; N Casuccio; M Palermo; K Bányai; V Martella; S DE Grazia Journal: Epidemiol Infect Date: 2016-01-08 Impact factor: 4.434
Authors: Virginie Banga-Mingo; Diane Waku-Kouomou; Jean Chrysostome Gody; Mathew D Esona; Jean Fandema Yetimbi; Regis Mbary-Daba; Benjamin A Dahl; Leon Dimanche; Thomas d'Aquin Koyazegbe; Vianney Tricou; Kathleen F Cavallaro; Gilbert Guifara; Michael D Bowen; Ionela Gouandjika-Vasilache Journal: Infect Genet Evol Date: 2014-09-02 Impact factor: 4.393